Heartbeam, Inc.

Greetings, and welcome to the HeartBeam fourth quarter and full year 2022 financial results conference call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. Before we begin the formal presentation, I would like to remind everyone that statements made on the call and webcast may include predictions, estimates, or other information that might be considered forward-looking. While these forward-looking statements represent our current judgment on what the future holds, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect our opinions only as of the date of this presentation. Please keep in mind that we are not obligating ourselves to revise or publicly release the results of any revision to these four looking statements in light of new information or future events. Throughout today's discussion, we will attempt to present some important factors relating to our business that may affect our predictions. You should also review our most recent Form 10-K and Form 10-Q for a more complete discussion of these factors and other risks. particularly under the heading Risk Factors. A press release detailing these results crossed the wires this afternoon at 4.01 p.m. Eastern Time and is available in the Investor Relations section of our company's website, heartbeam.com. Your host today, Branislav Vajic, Chief Executive Officer and Founder, Rob Eno, President, and Rick Brownstein, Chief Financial Officer, will present results of operations for the fourth quarter and year ended December 31st, 2022. At this time, I will turn the call over to HeartBeam Chief Executive Officer, Branislav Sajic. You may begin.

Thank you, operator, and good afternoon, everyone.

I'm pleased to welcome you to today's fourth quarter and full year 2022 Financial Results Conference call. I could not be more enthusiastic about the future for Harbin, the rapid pace of our product timeline and our team's ability to trace our commercialization path. For those of you joining us for the first time or whom I have not had the opportunity to meet, I'd like to take a moment to introduce Harbin and our opportunity in a short video introduction. The video explores the Heartbeam Amigo technology, need, market, opportunity, and use in the heart attack detection case. Heartbeam Amigo is the first and only credit card-sized 12-lead ECG device for remote heart attack detection. While we are playing the video for our dialing participants, unfortunately, it will be about three minutes of silence. But I'd like to remind you that this video is available on our website, heartbeat.com.